Publication | Open Access

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

Hematological MalignancyChronic Myeloid LeukemiaTransplantationMarrow TransplantationOncologyMixed-phenotype Acute LeukemiaImmunologyHematologyCell DoseLymphocyte InfusionsImmunotherapyMedicineCell TransplantationMyeloid Neoplasia